# Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors

> **NCT05137275** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Locally Advanced or Metastatic Solid Tumors

## Interventions

- **BIOLOGICAL:** Anti-5T4 CAR-raNK Cells

## Key facts

- **NCT ID:** NCT05137275
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-24
- **Primary completion:** 2023-04
- **Final completion:** 2023-05
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2022-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137275, "Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05137275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*